Gene Therapy for Rare Disorders Summit
VGXI is thrilled to be part of Gene Therapy for Rare Disorders Summit. Bringing together key figures from industry, regulatory bodies, patient non-profits, payers, and key service providers. The Gene Therapy for Rare Disorders Summit is the field’s foremost meeting for collectively progressing rare gene therapy programs into and through the clinic. Join us to leverage essential insights from over 200 peers from leading biopharma companies with direct experience in driving gene therapies through the clinic and into the market.
Meet the VGXI Team
VGXI’s Associate Director of Business Development, Michelle Stretz, is attending and looks forward to discussing our latest technology innovations and plasmid DNA manufacturing solutions to accelerating safe, effective and accessible Gene Therapies in Rare Disease. Complete the form below to schedule a meeting during the 7th Annual Gene Therapy for Rare Disorders to explore how VGXI can support your gene therapy needs. We look forward to seeing you in Boston!
